Flagship-backed microbiome company Kaleido Biosciences shuts down – Endpoints News

Just a few years ago, the pharma industry was labeled as a big-time carbon polluter in a study that showed greenhouse gas emissions that were 55% higher than the auto industry. The study and media reports that followed expressed some shock amid surprisingly scant attention paid to the industry by environmental watchers.

Since then, however, pharma companies have taken up the challenge – including efforts by many to drive to non-zero emission goals. AstraZeneca, along with Novartis and Merck, is leading the time race in the industry, setting company goals for 2025, followed by a larger group of pharmas aiming for 2030. ESG tracker SPGlobal notes J&J, Pfizer, GlaxoSmithKline, Sanofi and BioNTech among the latter group.

Leave a Reply

Your email address will not be published.